PRUCALOPRIDE MEDSURGE prucalopride (as succinate) 1 mg tablet blister pack

Држава: Аустралија

Језик: Енглески

Извор: Department of Health (Therapeutic Goods Administration)

Активни састојак:

prucalopride succinate, Quantity: 1.321 mg (Equivalent: prucalopride, Qty 1 mg)

Доступно од:

Medsurge Pharma Pty Ltd

Фармацеутски облик:

Tablet

Састав:

Excipient Ingredients: titanium dioxide; lactose monohydrate; macrogol 400; colloidal anhydrous silica; magnesium stearate; hypromellose; polysorbate 80; microcrystalline cellulose

Пут администрације:

Oral

Јединице у пакету:

28 tablets

Тип рецептора:

(S4) Prescription Only Medicine

Терапеутске индикације:

Prucalopride is indicated for the treatment of chronic functional constipation in adults in whom laxatives fail to provide adequate relief.,? Before Prucalopride is considered patients must have tried at least two different types of laxatives from different classes (at the highest tolerated recommended doses) for at least six months, but have not had adequate relief from constipation.,? If treatment with Prucalopride is not effective within four weeks, the benefit of continuing treatment should be reconsidered.

Резиме производа:

Visual Identification: White to off-white, circular, film coated tablet with 'C' debossed on one side and '11' on the other side.; Container Type: Blister Pack; Container Material: PVC/PE/PCTFE (Aclar)/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Статус ауторизације:

Registered

Датум одобрења:

2022-02-04